TPCW
DGX icon

TD Private Client Wealth’s Quest Diagnostics DGX Stock Holding History

TD Private Client Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
2,806
-476
-15% -$93.4K 0.01% 462
2026
Q1 		$643K Sell
3,282
-418
-11% -$81.2K 0.01% 439
2025
Q4 		$642K Sell
3,700
-357
-9% -$65K 0.01% 426
2025
Q3 		$773K Buy
4,057
+488
+14% +$86.6K 0.02% 406
2025
Q2 		$641K Buy
3,569
+1,090
+44% +$189K 0.02% 432
2025
Q1 		$420K Buy
2,479
+2,156
+667% +$354K 0.01% 469
2024
Q4 		$48.8K Buy
323
+11
+4% +$1.71K ﹤0.01% 823
2024
Q3 		$48.5K Buy
312
+6
+2% +$896 ﹤0.01% 832
2024
Q2 		$41.9K Buy
306
+45
+17% +$6.16K ﹤0.01% 839
2024
Q1 		$34.7K Buy
261
+15
+6% +$1.95K ﹤0.01% 875
2023
Q4 		$33.9K Buy
246
+5
+2% +$657 ﹤0.01% 884
2023
Q3 		$29.4K Sell
241
-25
-9% -$3.33K ﹤0.01% 874
2023
Q2 		$37.4K Sell
266
-44
-14% -$6.07K ﹤0.01% 839
2023
Q1 		$43.9K Buy
310
+8
+3% +$1.15K ﹤0.01% 795
2022
Q4 		$47.2K Buy
302
+27
+10% +$3.88K ﹤0.01% 755
2022
Q3 		$33.7K Buy
275
+17
+7% +$2.24K ﹤0.01% 811
2022
Q2 		$34.3K Sell
258
-17
-6% -$2.32K ﹤0.01% 808
2022
Q1 		$37.6K Sell
275
-105
-28% -$14.6K ﹤0.01% 826
2021
Q4 		$65.7K Sell
380
-19
-5% -$2.89K ﹤0.01% 704
2021
Q3 		$58K Sell
399
-16
-4% -$2.34K ﹤0.01% 724
2021
Q2 		$54.8K Sell
415
-2
-0.5% -$262 ﹤0.01% 721
2021
Q1 		$53.5K Sell
417
-28
-6% -$3.45K ﹤0.01% 695
2020
Q4 		$53K Sell
445
-1,846
-81% -$225K ﹤0.01% 656
2020
Q3 		$262K Sell
2,291
-892
-28% -$105K 0.01% 424
2020
Q2 		$363K Sell
3,183
-294
-8% -$31.2K 0.02% 388
2020
Q1 		$279K Sell
3,477
-4,348
-56% -$450K 0.02% 386
2019
Q4 		$836K Buy
+7,825
New +$816K 0.05% 286

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

TD Private Client Wealth's DGX Position: Q2 2026 in Review

TD Private Client Wealth reduced its Quest Diagnostics (DGX) stake by 15% in Q2 2026, selling an estimated $93.4K and leaving 2,806 shares worth $595K. The position accounts for 0.01% of the portfolio, ranked #462.

TD Private Client Wealth first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $836K in Q4 2019. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • TD Private Client Wealth held 2,806 shares of Quest Diagnostics worth $595K as of Q2 2026.
  • TD Private Client Wealth sold 476 Quest Diagnostics shares in Q2 2026, an estimated $93.4K.
  • Quest Diagnostics made up 0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #462 holding.
  • TD Private Client Wealth first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Quest Diagnostics position peaked at $836K in Q4 2019.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.